Literature DB >> 3041029

Transforming potential of a myc-containing variant of feline leukemia virus in vitro in early-passage feline cells.

L Bonham, P A Lobelle-Rich, L A Henderson, L S Levy.   

Abstract

We studied a naturally occurring variant of feline leukemia virus (FeLV) in which the oncogene myc has substituted for a portion of the viral structural genes (myc-FeLV). myc-FeLV was rescued by replication in the presence of FeLV as helper, and its biological activity was examined in early-passage feline cells in vitro. Infection of leukocytes from peripheral blood, spleen, or thymus, or of kitten fibroblasts did not immortalize these cells or alter them morphologically. Northern blot (RNA blot) analysis of virion RNA prepared from the supernatant of infected cells demonstrated the 8.2-kilobase genome of FeLV, but did not demonstrate the 5.0-kilobase genome of myc-FeLV. Apparently, the myc-FeLV genome was lost in the absence of the selective pressure of transformation. In contrast, infection of embryonic fibroblasts with myc-FeLV(FeLV) rendered these cells capable of greatly increased, if not infinite, proliferative potential. The cells were morphologically altered compared with controls and were only loosely adherent to the substrate. The cells failed to proliferate in semisolid medium and did not form tumors when inoculated subcutaneously into athymic mice. Blot analyses demonstrated the presence and expression of integrated proviral DNAs of both FeLV and myc-FeLV in these cells. They appear, then, to represent cells partially transformed by infection with myc-FeLV(FeLV). The action of feline v-myc in early-passage cells in vitro was compared to that of avian v-myc.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3041029      PMCID: PMC255882          DOI: 10.1128/JVI.61.10.3072-3081.1987

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

Review 1.  Cat leukemia and its viruses.

Authors:  W F Jarrett
Journal:  Adv Vet Sci Comp Med       Date:  1975

2.  The frequency of occurrence of feline leukaemia virus subgroups in cats.

Authors:  O Jarrett; W D Hardy; M C Golder; D Hay
Journal:  Int J Cancer       Date:  1978-03-15       Impact factor: 7.396

3.  A general method for isolation of high molecular weight DNA from eukaryotes.

Authors:  N Blin; D W Stafford
Journal:  Nucleic Acids Res       Date:  1976-09       Impact factor: 16.971

4.  Transformation parameters in chicken fibroblasts transformed by AEV and MC29 avian leukemia viruses.

Authors:  B Royer-Pokora; H Beug; M Claviez; H J Winkhardt; R R Friis; T Graf
Journal:  Cell       Date:  1978-04       Impact factor: 41.582

5.  Immunofluorescent studies of RD-114 virus replication in cell culture.

Authors:  J L Riggs; R M McAllister; E H Lennette
Journal:  J Gen Virol       Date:  1974-10       Impact factor: 3.891

6.  Determinants of the host range of feline leukaemia viruses.

Authors:  O Jarrett; H M Laird; D Hay
Journal:  J Gen Virol       Date:  1973-08       Impact factor: 3.891

7.  Enhancement and inhibition of avian sarcoma viruses by polycations and polyanions.

Authors:  K Toyoshima; P K Vogt
Journal:  Virology       Date:  1969-07       Impact factor: 3.616

8.  Influence of prednisolone on Moloney leukemogenic virus in BALB-c mice.

Authors:  H T Abelson; L S Rabstein
Journal:  Cancer Res       Date:  1970-08       Impact factor: 12.701

9.  A membrane-filter technique for the detection of complementary DNA.

Authors:  D T Denhardt
Journal:  Biochem Biophys Res Commun       Date:  1966-06-13       Impact factor: 3.575

10.  Simple, quantitative assay for both xenotropic murine leukemia and ecotropic feline leukemia viruses.

Authors:  P J Fischinger; C S Blevins; S Nomura
Journal:  J Virol       Date:  1974-07       Impact factor: 5.103

View more
  9 in total

Review 1.  Receptor-mediated leukaemogenesis: hypothesis revisited.

Authors:  J C Neil; R Fulton; R McFarlane; M Rigby; M Stewart; A Terry; T Tzavaras
Journal:  Br J Cancer Suppl       Date:  1988-12

2.  Tumorigenic potential of a recombinant retrovirus containing sequences from Moloney murine leukemia virus and feline leukemia virus.

Authors:  C R Starkey; P A Lobelle-Rich; S W Granger; S Granger; B K Brightman; H Fan; L S Levy
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

3.  Tumorigenic potential of a myc-containing strain of feline leukemia virus in vivo in domestic cats.

Authors:  L S Levy; R E Fish; G B Baskin
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

4.  Apparent uncoupling of oncogenicity from fibroblast transformation and apoptosis in a mutant myc gene transduced by feline leukemia virus.

Authors:  R Fulton; R Gallagher; D Crouch; J C Neil
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

5.  Insertional mutagenesis of flvi-2 in tumors induced by infection with LC-FeLV, a myc-containing strain of feline leukemia virus.

Authors:  L S Levy; P A Lobelle-Rich
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

6.  Function of a unique sequence motif in the long terminal repeat of feline leukemia virus isolated from an unusual set of naturally occurring tumors.

Authors:  G B Athas; P Lobelle-Rich; L S Levy
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

Review 7.  Viral determinants of FeLV infection and pathogenesis: lessons learned from analysis of a natural cohort.

Authors:  Lisa L Bolin; Laura S Levy
Journal:  Viruses       Date:  2011-09-09       Impact factor: 5.048

Review 8.  Infectious Causes of Neoplasia in the Domestic Cat.

Authors:  Kerry E Rolph; Ryan P Cavanaugh
Journal:  Vet Sci       Date:  2022-08-30

Review 9.  Haematological disorders associated with feline retrovirus infections.

Authors:  M L Linenberger; J L Abkowitz
Journal:  Baillieres Clin Haematol       Date:  1995-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.